A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory D
| Image |  |
|---|---|
| Description | scientific article published on 13 July 2020 |
| Author/s |
author: Amy Pace Shamsah Kazani Stephan Ortiz |
| Publication date | July 13, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |